Well done Ben for your always fact driven and neutral writings. Keep it up as rarely see writer in i3 forum try as hard to keep it this way. Not many have the knowledge and time to gather those information for them as a guide to make their own investment decision. Nobody will always right. I hope more people entering the forum, particularly this one will practice constructive argument instead of emotional venting which serve no good for anyone.

Hi Ben,

Do you keep tracking these:"2. Net buyers and net sellers of Supermax stock for the week of 15-19 February" for subsequent week?

Thanks Ben for the PV analysis which are very informative. Just a clarification questions, I noticed in Supermax 31-December 2020 BS, there was Prepayment received from customers at 1,477,430 in current liability, any reason you didn't substrate this amount from the cash on ~3.7B?

Thanks Ben for the excellent works to share these meaningful info! Wishing you and everyone here an oxpicious and bullish Niu Year. May god bless you with great health and abundance happiness! I hope Ben can also share with us if you have done an analysis on impact scenarios for the pending Feb 2021 expiry warrants for Top Glove and Supermax.

anyone have any insiders' news about the just closed Q4'2020 QR? a profit will be a great booster!

This company worth more study...

I am also hoping that Pelikan will turn in a profit this Q4 2020! Just want to be correct with reality. I hope their Asia push will finally bear fruits!

@lee_m2020 this is misleading...as Pelikan International has been reporting losses almost every 4th quarter in last few years!

PELIKAN Quarter Report History
Date Financial
Year Quarter Revenue
(RM,000) PBT (RM,000) Net Profit
(RM,000) EPS (Cent) Div
(Cent) NTA
(RM) QoQ
(%) YoY
(%)
26 Nov 20 31 Dec 20 Q3 Sep 20 314,589 21,210 15,060 2.50 0.00 0.750 Malaysia Stock - KLSE Quarter Report History 25% Malaysia Stock - KLSE Quarter Report History 208%
17 Aug 20 31 Dec 20 Q2 Jun 20 255,412 20,590 20,096 3.33 0.00 0.730 Malaysia Stock - KLSE Quarter Report History 341% Malaysia Stock - KLSE Quarter Report History 10%
28 May 20 31 Dec 20 Q1 Mar 20 207,278 -6,286 -8,334 -1.38 0.00 0.690 Malaysia Stock - KLSE Quarter Report History 52% Malaysia Stock - KLSE Quarter Report History 538%
27 Feb 20 31 Dec 19 Q4 Dec 19 223,266 -17,286 -17,418 -2.89 0.00 0.730 Malaysia Stock - KLSE Quarter Report History 456% Malaysia Stock - KLSE Quarter Report History 24%
22 Nov 19 31 Dec 19 Q3 Sep 19 303,310 9,765 4,890 0.83 0.00 0.760 Malaysia Stock - KLSE Quarter Report History 73% Malaysia Stock - KLSE Quarter Report History 189%
29 Aug 19 31 Dec 19 Q2 Jun 19 316,489 21,759 18,321 3.34 0.00 0.810 Malaysia Stock - KLSE Quarter Report History 864% Malaysia Stock - KLSE Quarter Report History 12%
23 May 19 31 Dec 19 Q1 Mar 19 217,633 6,180 1,901 0.35 0.00 0.770 Malaysia Stock - KLSE Quarter Report History 114% Malaysia Stock - KLSE Quarter Report History 31%
21 Feb 19 31 Dec 18 Q4 Dec 18 222,802 -7,027 -13,993 -2.55 0.00 0.790 Malaysia Stock - KLSE Quarter Report History 928% Malaysia Stock - KLSE Quarter Report History 46543%
15 Nov 18 31 Dec 18 Q3 Sep 18 321,021 6,029 1,690 0.31 0.00 0.850 Malaysia Stock - KLSE Quarter Report History 90% Malaysia Stock - KLSE Quarter Report History 78%
28 Aug 18 31 Dec 18 Q2 Jun 18 336,780 24,457 16,425 3.00 0.00 0.820 Malaysia Stock - KLSE Quarter Report History 500% Malaysia Stock - KLSE Quarter Report History 3%
24 May 18 31 Dec 18 Q1 Mar 18 243,391 5,848 2,739 0.50 0.00 0.810 Malaysia Stock - KLSE Quarter Report History 9230% Malaysia Stock - KLSE Quarter Report History 171%
28 Feb 18 31 Dec 17 Q4 Dec 17 254,320 -15,648 -30 -0.01 0.00 0.810 Malaysia Stock - KLSE Quarter Report History 100% Malaysia Stock - KLSE Quarter Report

Other than TGIF and Teh Tarik Place, the $25 mil investment in Quangxi Aerospace Beidou companies via Hong Kong vehicle is very fishy! The so called low cost Ruthenium battery with 10X more storage capacity and 10X more durable will be jewel of PRC if true is unlikely to be sold to overseas company!

Unlikely this tiny companies ( and Bintai, Yong Tai and etc) without track record can eventual deliver vaccine in Malaysia...even if they can, what can their value be? Simple, even big glove companies with decades of track records and making billions now, PER using latest Qtr are mostly in single digit, most analyst are not daring to give them high valuation because these are supernormal! So even if this tiny companies pull through a miracle for the so called covid-19 vaccine distribution JV, how long and how much can they make? Are we feeding the sharks?

Yong Tai plan to raise RM90 mil through private placement to pay dues to main contractors of Impression Melaka and Impression U-Thant! So that tell a lot the company is in very poor financial health! The stock being goreng to let’s major shareholders to cash out some in open market!

If you are playing with 10% of your Capital for Bintai, Solution, HWGB and etc, have fun. But if you put in 90% of what you have, be prepared to pick up yourself later.

Even if the top 3 Chinese vaccine approved for Malaysia, it will not be through small fries like Bintai or Solution...wait up! If you have made money - cash out, if you haven’t enter - don’t gamble with shark, if you are stuck- too bad!

Hard to see value in this stock! It is not smart to believe in the vaccine news!

Daily88, this stock do have a profitable biz, unlike many recent covid-19 vaccines rumors losing money counters! But the eps will need to grow a lot base on current price of ~17.5 sen that is already doubled what TS Chan paid for at 8.5 sen and probably why Nirwana boss cashout on opportunity.

In the last few days, they goreng the vaccine news that caused a spike which allowed a major shareholder in HK to cash out at almost 40 sen a share for 7.3% of the company shares worth RM29mil!

Some report said it was just a transfer from the biggest shareholders before this. But at the same time, Nirwana boss another TS ceased to be the major shareholder about the same time.

In the Bursa declaration TS Chan was financed by PBB, not sure if margin Financing. But 228Mil shares at 8.5 sen was less than RM20Mil!

Did you hear so many companies JV for vaccines in Singapore? Invest base on their core biz of property development, else we likely get burn!

But TS Chan got the 228Mil shares at 8.5sen per share...versus now.

banker are coming in to support at 36 sen, run if you have recover some!

This Q4 2020 will be critical whether they can turn in at profit for the first time in many years! Else hard to fly!

stationery stock sub-sub sector!

too many shares now at 2.245Bil! that is why even at 18 sen PER is high at 34!

In the coming AGM, if accepted, they will consolidate 2 shares into one!

This stock has total 1.402Bil shares and today up to now transacted 0.674Bil shares, so who is frying? Just be careful is a all out "goreng"...the company has not make a meaningful profit for 9 quarters!

Good opportunity to run if we have stuck too long in this stock! All the news are likely hot air as why will reputable vaccine companies want to partner all these small fries all with bad track records!

On 1-12-2020, the 228 mil shares (~10%) of this stock changed hand ar substantial shareholder to ex MCA minister for 8.5 sen for whatever reason but even the best for last 4 Qtr eps only 0.15 sen!

Realistically, as their main Market for now are Germany, the rest of Europe and South America, their schools opening are in Q3 of the year.

I hope to see Pelikan able to turn a profit for Q4 which shall proof the company stock worth at least 2 times current price!

Actually Q3'2020 PBT (RM21.2M) was slightly higher than Q2'2020 (RM20.6) but Q2 was zero tax that was why the PAT lower at RM15M!

I wish you are right...but it depend on what is the projection for Q4'2020 EPS. This stock 52 weeks high is only RM0.59 even though its NTA is RM0.75! The company has not been very successful in last 3 qtrs to expand SEA, Far East include China and Middle East business.

Many may already forgotten Pelikan sold 10% stake to Nazir's PE firm Ikhlas Capital in Q3 2019 ay RM0.39 a share with a premium of about 15.73%.

https://www.theedgemarkets.com/article/pelikan-sell-10-stake-nazirs-pe-firm-ikhlas-capital.

This stationery stock is likely a slow and steady one instead being "goreng" up and down!

If we look at 4.45 sen YTD EPS and if Q4’20 EPS continue positive (Q4 usually a tough Qtr for Pelikan after school open completed), Pelikan is much better bet than many listed so called ‘hot’ companies in Bursa! Furthermore, stationery biz are so much easier to manage and predict as compare to many others.


Confession: I own some Pelikan shares pick up last 2 weeks.